Home/Filings/4/0001104659-17-046277
4//SEC Filing

Cavan John T 4

Accession 0001104659-17-046277

CIK 0001583771other

Filed

Jul 20, 8:00 PM ET

Accepted

Jul 21, 4:01 PM ET

Size

5.2 KB

Accession

0001104659-17-046277

Insider Transaction Report

Form 4
Period: 2017-07-20
Cavan John T
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2017-07-20+15,000133,688 total
    Exercise: $0.58Exp: 2027-07-20Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]Options vest in three installments as follows: 5,000 vest on each of July 20, 2018, 2019 and 2020.

Documents

1 file

Issuer

ContraVir Pharmaceuticals, Inc.

CIK 0001583771

Entity typeother

Related Parties

1
  • filerCIK 0001503738

Filing Metadata

Form type
4
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 4:01 PM ET
Size
5.2 KB